STXS Stereotaxis Inc

$STXS if business was dying they probably would not have done the recent merger. They do have sales and a great product and business model. I predict a larger company buying them this winter

$STXS company has long awaited products, steadily growing revenue, cash in bank. It shouldn’t be trading for a $1.33! Market cap is $132 million.

$STXS they need a reliable manufacturer of magic catheters . Without a reliable supplier few will buy Genesis

$STXS Fingers crossed that STXS has established a double bottom, despite tax loss selling.

$STXS - stick can double or triple easily- They need to shed some more light on whats hoing on - But im syill a nobbke roght here for the longer term-

$STXS The following is an AI summary: "Stereotaxis is the primary stock discussed by Zacks Equity Research in direct comparison with Intuitive Surgical. The discussion centers on the intensifying global competition in the robotic surgery market and how both companies are integrating (AI). Zacks highlights that Stereotaxis is embedding AI and automation into its robotic ecosystems via its digital surgery platforms, Synchrony and SynX...Zacks notes that the expansion of ecosystems like Stereotaxis creates long-term competitive headwinds for ISRG."

$STXS Is it possible that knowledge that a product is currently being upgraded could cause a temporary reluctance to buy the current version?